Charles River and Akron link to integrate cytokines into cell therapy
The integration enables closed system processing, a significant step in automating platforms and protocols for cell therapies.
Cytiva Pipe dream to pipeline WP 3
Intellia slashes workforce by 27% to focus on late stage CRISPR candidates
Coave Therapeutics raises $33m in funding to advance ALIGATER platform
Vertex and Orna sign partnership to improve efficiencies of gene therapies
Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
Roche to acquire Poseida Therapeutics for $1.5bn
Novartis acquires Kate Therapeutics to advance gene therapies
